|
⚲
|
| Keyboard |
| Ayer Capital Management LP
✚
|
|
|---|---|
| CRD # | 157867 |
| SEC # | 801-74300 |
| CIK # | 0001471149 |
| AUM | |
| Employees | 2 (50% Investors, 0% Brokers) |
| Phone | 530-988-8879 |
| Address | 3218 Via Verde Terrace Davis, CA 95618 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Ayer Capital Partners Kestrel Fund LP | [2012-02-16] | 2.2 M | 1.2 M |
| Filed 2009-09-30 (D/A) · Exemption 506, 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ayer Capital Partners Master Fund LP | [2012-02-16] | 33.2 M | 41.2 M |
| Filed 2009-09-30 (D/A) · Exemption 506, 3(c), 3(c)(7) · Minimum $3,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ayer Special Situations Fund I LP | 2012-02-16 | 2.5 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 45.5 |
| By Discretionary | ||
| Discretionary | 6 | 45.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 45.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 45.5 | |
| Total | 6 | 45.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jay Venkatesan | Promoter | 31 | 2 | |
| Ayer Capital Management LP | Promoter | 3 | 2 | |
| Ayer Kestrel Partners LLC | Executive Officer | 1 | 1 | |
| Ayer Capital Partners LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001471149] | |
| 3 | [0001471149] | |
| 4 | [0001471149] | |
| 5 | [0001471149] | |
| SC 13G | [0001471149] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.0B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ACM Capital Partners LLC | |
| Ayer Capital Management LP | |
| Ayer Capital Partners LLC | |
| Iovance Biotherapeutics Inc | |
| Venkatesan Jay | |
| Insmed Inc | |
| Abeona Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Iovance Biotherapeutics Inc LBIO
Common Stock
|
2015-05-01 | Sell | 2,780,682 | $9.62 | 26,750,161 |
|
Iovance Biotherapeutics Inc GNBP
Warrant · derivative
|
2013-05-22 | Conversion | 1 | $0.00 | |
|
Iovance Biotherapeutics Inc GNBP
Convertible Note · derivative
|
2013-05-22 | Conversion | 1 | $1.25 | 1 |
|
Iovance Biotherapeutics Inc GNBP
Corporate Loan · derivative
|
2013-05-22 | Conversion | 1 | $1.25 | 1 |
|
Iovance Biotherapeutics Inc GNBP
Warrant · derivative
|
2013-05-22 | Conversion | 1 | $0.00 | |
|
Iovance Biotherapeutics Inc GNBP
Warrant · derivative
|
2013-05-22 | Conversion | 1 | $0.00 | |
|
Iovance Biotherapeutics Inc GNBP
Common stock
|
2013-05-22 | Other | 5,600,887 | $4.90 | 27,444,346 |
|
Iovance Biotherapeutics Inc GNBP
Corporate Loan · derivative
|
2013-05-22 | Conversion | 1 | $1.25 | 1 |
|
Iovance Biotherapeutics Inc GNBP
Warrant · derivative
|
2013-05-22 | Conversion | 1 | $0.00 | |
|
Iovance Biotherapeutics Inc GNBP
Convertible Note · derivative
|
2013-05-22 | Conversion | 1 | $1.25 | 1 |
|
Iovance Biotherapeutics Inc GNBP
Common stock
|
2013-05-22 | Other | 560,088,650 | $0.05 | 28,004,432 |
|
Abeona Therapeutics Inc ACCP
Common stock
|
2012-06-29 | Sell | 179,157 | $0.55 | 98,536 |
|
Abeona Therapeutics Inc ACCP
Common stock
|
2012-06-28 | Sell | 25,000 | $0.68 | 17,000 |
|
Abeona Therapeutics Inc ACCP
Common stock
|
2012-05-16 | Sell | 140,300 | $0.67 | 94,001 |
|
Abeona Therapeutics Inc ACCP
Common stock
|
2012-05-15 | Sell | 1,000 | $0.85 | 850 |